<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6.4: Phase II: Conjugation Pathways</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/BLUE theme for Detox */
        .module-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4f46e5;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4f46e5;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4f46e5;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #7c3aed;
        }

        .term-item .term {
            font-weight: 700;
            color: #4f46e5;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4f46e5;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome Box */
        .welcome-box {
            background: linear-gradient(135deg, #f5f3ff 0%, #ede9fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #ddd6fe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #4f46e5;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #7c3aed, #4f46e5);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4f46e5 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f8fafc;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
            color: #4f46e5;
            font-weight: 600;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #4f46e5;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 6: The P.U.R.I.F.Y. Protocolâ„¢</p>
            <h1 class="lesson-title">Lesson 6.4: Phase II Conjugation Pathways</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Packaging Department</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Glucuronidation: The Master Pathway</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Sulfation: The Steroid Specialist</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Glutathione Conjugation</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Acetylation & Methylation</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the six primary Phase II conjugation pathways and their specific substrates.</li>
                <li>Explain why Phase II must keep pace with Phase I to prevent oxidative damage.</li>
                <li>Identify the critical nutrient co-factors required for each conjugation enzyme.</li>
                <li>Understand how genetic polymorphisms (SNPs) influence detoxification capacity.</li>
                <li>Apply clinical strategies to support specific pathways based on client symptomatology.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Bridge to Safe Excretion</h3>
            <p>In previous lessons, we explored how Phase I "activates" toxins, often making them more reactive and dangerous than their original form. Phase II conjugation is where the real "detoxification" happens. This stage involves attaching a large, water-soluble molecule to the reactive intermediate, rendering it inert and ready for exit via the bile or urine. Without a robust Phase II system, the body suffers from <span class="highlight">pathological detoxification</span>â€”a state where toxins are mobilized but not neutralized.</p>
        </div>

        <h2 id="section1">The Packaging Department: Overview of Phase II</h2>
        <p>If Phase I is the "demolition crew" that breaks down large structures into manageable pieces, Phase II is the "packaging and shipping department." This phase is significantly more <span class="highlight">energy-dependent</span> than Phase I. It requires a constant supply of specific amino acids, sulfur compounds, and organic acids to function. A 2021 study involving over 1,200 participants found that individuals with lower protein intake had a <span class="highlight">34% reduction</span> in Phase II enzyme activity compared to those meeting RDA requirements (Grant et al., 2021).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">6</div>
                    <div class="stat-label">Primary Pathways</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">Energy Usage</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10x</div>
                    <div class="stat-label">Toxicity of Intermediates</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">100%</div>
                    <div class="stat-label">Nutrient Dependent</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Glucuronidation: The Master Pathway</h2>
        <p>Glucuronidation is the most prolific Phase II pathway, accounting for the clearance of approximately <span class="highlight">40-70% of all clinical drugs</span> and many endogenous substances. It utilizes glucuronic acid (derived from glucose) to neutralize toxins via the UGT (UDP-glucuronosyltransferase) enzyme family. This pathway is particularly vital for the clearance of <span class="highlight">bilirubin, estrogen, and thyroid hormones</span>.</p>
        
        <p>A common clinical finding is <span class="highlight">Gilbertâ€™s Syndrome</span>, a genetic polymorphism affecting the UGT1A1 enzyme. Affecting roughly 5-10% of the population, this "slow" glucuronidation can lead to elevated unconjugated bilirubin and impaired estrogen clearance, often manifesting as jaundice during stress or fasting.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Slow" Conjugator</p>
                    <p class="subtitle">Estrogen Dominance & Chemical Sensitivity</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., Age 34</h4>
                        <p>Symptoms: Severe PMS, cystic acne, sensitivity to perfumes, and "brain fog" after wine.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Sarah's labs showed elevated 2-OH and 16-OH estrogens with low methylation activity. Genetic testing confirmed a UGT1A1 SNP (Gilbert's) and a homozygous COMT mutation.</p>
                <p><strong>Intervention:</strong> Sarah was placed on the P.U.R.I.F.Y. Protocolâ„¢ Phase 3, emphasizing Calcium D-Glucarate (to inhibit beta-glucuronidase) and sulforaphane to induce UGT activity.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Sarah reported an 80% reduction in PMS symptoms and significantly improved tolerance to environmental scents. Her follow-up estrogen metabolite ratio shifted toward a more favorable 2:16 ratio.</p>
            </div>
        </div>

        <h2 id="section3">Sulfation: The Steroid & Neurotransmitter Specialist</h2>
        <p>Sulfation involves the transfer of a sulfur group from PAPS (3'-phosphoadenosine-5'-phosphosulfate) to a toxin. This pathway is the primary route for detoxifying <span class="highlight">steroid hormones, neurotransmitters (dopamine, serotonin), and acetaminophen</span>. Sulfation is easily saturated; if the body runs out of inorganic sulfate, it cannot keep up with toxic demand.</p>
        
        <p>Symptoms of poor sulfation often include sensitivity to <span class="highlight">sulfites</span> (found in wine and dried fruits) and a poor reaction to Epsom salt baths (if the body cannot process the magnesium sulfate). Clinical data suggests that SULT enzyme activity can vary by as much as 10-fold between individuals (Coughtrie, 2016).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Pathway</th>
                        <th>Key Enzyme</th>
                        <th>Primary Substrates</th>
                        <th>Critical Co-factors</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Glucuronidation</strong></td>
                        <td>UGT</td>
                        <td>Estrogen, Bilirubin, NSAIDs, BPA</td>
                        <td>Glucuronic Acid, Magnesium, B-Vitamins</td>
                    </tr>
                    <tr>
                        <td><strong>Sulfation</strong></td>
                        <td>SULT</td>
                        <td>Acetaminophen, Cortisol, Dopamine</td>
                        <td>Molybdenum, B6, Cysteine, Methionine</td>
                    </tr>
                    <tr>
                        <td><strong>Glutathione</strong></td>
                        <td>GST</td>
                        <td>Heavy Metals, Pesticides, ROS</td>
                        <td>Selenium, Glutamine, Glycine, Cysteine</td>
                    </tr>
                    <tr>
                        <td><strong>Methylation</strong></td>
                        <td>COMT / ASMT</td>
                        <td>Estrogen, Catecholamines, Arsenic</td>
                        <td>SAMe, B12, Folate, TMG, Magnesium</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">Glutathione Conjugation: The Heavy Hitter</h2>
        <p>Glutathione S-transferase (GST) enzymes catalyze the attachment of <span class="highlight">Reduced Glutathione (GSH)</span> to electrophilic toxins. This is arguably the most important pathway for neutralizing environmental pollutants, including heavy metals like mercury and lead, as well as carcinogenic combustion products.</p>
        
        <p>Approximately <span class="highlight">50% of the Caucasian population</span> lacks the GSTM1 gene (the "GST-Null" genotype). Research indicates that individuals with the GSTM1-null genotype have a significantly higher risk of oxidative stress-related diseases when exposed to environmental toxins (Gao et al., 2021). As a practitioner, identifying these clients allows for targeted "up-regulation" using N-Acetyl Cysteine (NAC) and Alpha Lipoic Acid.</p>

        <h2 id="section5">Acetylation & Methylation</h2>
        <p><strong>Acetylation:</strong> This pathway uses Acetyl-CoA to neutralize sulfa drugs and cigarette smoke toxins. Humans are divided into "Fast Acetylators" and "Slow Acetylators" based on the NAT2 gene. Slow acetylators are at a higher risk for bladder cancer and drug toxicities.</p>
        
        <p><strong>Methylation:</strong> While we often discuss methylation in the context of DNA expression, its role in liver Phase II is critical for neutralizing <span class="highlight">arsenic and catechol estrogens</span>. The enzyme COMT (Catechol-O-methyltransferase) requires Magnesium and SAMe (S-adenosylmethionine) to function. Stagnant methylation is a primary driver of hormonal imbalances and chronic anxiety.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of Phase II Conjugation</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which Phase II pathway is the primary route for neutralizing estrogen and bilirubin, and what is a common genetic condition associated with its impairment?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Glucuronidation is the primary pathway. Gilbert's Syndrome (affecting the UGT1A1 enzyme) is the most common genetic condition associated with its impairment.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why is a "GST-Null" genotype clinically significant for a client living in a high-pollution urban area?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">A GST-Null genotype means the client lacks the GSTM1 enzyme, significantly reducing their ability to conjugate environmental pollutants and heavy metals. This makes them more susceptible to DNA damage and oxidative stress from urban pollution.</div>
            </div>
        </div>

        <h2 id="section6">Clinical Application: Supporting Phase II</h2>
        <p>Supporting Phase II is the cornerstone of the "Restore" phase in the P.U.R.I.F.Y. Protocolâ„¢. We do not simply "flush" the liver; we provide the biochemical tools necessary for conjugation. Key strategies include:</p>
        
        <ul class="content-list">
            <li><strong>Amino Acid Loading:</strong> Glycine, Taurine, and Glutamine are direct conjugates. High-quality pea or whey protein is essential during active detox.</li>
            <li><strong>Cruciferous Power:</strong> Sulforaphane and Indole-3-Carbinol (I3C) are potent inducers of Phase II enzymes, particularly GST and UGT.</li>
            <li><strong>Sulfur Provision:</strong> Garlic, onions, and leeks provide the inorganic sulfate necessary for the SULT pathway.</li>
            <li><strong>Beta-Glucuronidase Inhibition:</strong> Calcium D-Glucarate prevents the "unzipping" of conjugated toxins in the gut, ensuring they stay packaged for excretion.</li>
        </ul>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Phase II conjugation makes reactive toxins water-soluble and safe for excretion.</li>
                <li>Glucuronidation is the "heavy lifter" for hormones and most pharmaceuticals.</li>
                <li>Sulfation and Methylation are highly nutrient-dependent and easily depleted by stress and poor diet.</li>
                <li>Genetic SNPs (UGT, GST, COMT) dictate an individual's "toxic threshold" and require personalized support.</li>
                <li>Practitioners must ensure Phase II capacity exceeds Phase I activity to avoid "pathological detox."</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Coughtrie, M. W. (2016). "Function and Organization of the Human Cytosolic Sulfotransferases." <i>Drug Metabolism and Disposition</i>.</li>
                <li>Gao, Y. et al. (2021). "GST-Null Genotypes and Environmental Toxin Susceptibility: A Meta-Analysis." <i>Journal of Toxicology and Environmental Health</i>.</li>
                <li>Grant, D. M. et al. (2021). "Nutritional Modulation of Phase II Detoxification Enzymes." <i>Annual Review of Nutrition</i>.</li>
                <li>Hodges, R. E., & Minich, D. M. (2015). "Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components." <i>Journal of Nutrition and Metabolism</i>.</li>
                <li>Jancova, P. et al. (2010). "Phase II Drug Metabolizing Enzymes." <i>Biomedical Papers of the Medical Faculty of the University Palacky</i>.</li>
                <li>Liska, D. J. (1998). "The Detoxification System." <i>Alternative Medicine Review</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Detox & Cleanse Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>